FDA Drug recall D-0338-2018
Megestrol Acetate Oral Suspension, USP 400 mg/ 10mL (10 mL UD cups in boxes of 20 cups), Rx Only, Dist
- FDA Drug
- Class III
- terminated
- Published 2018-02-14
On 2018-02-14 the FDA classified a Class III recall of Megestrol Acetate Oral Suspension, USP 400 mg/ 10mL (10 mL UD cups in boxes of 20 cups), Rx Only, Dist by Mckesson Packaging Services, citing subpotent Drug: Out of specification for assay (stability testing).
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0338-2018 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2018-01-29 |
| Published | 2018-02-14 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Mckesson Packaging Services |
| Distribution | US |
Product
Megestrol Acetate Oral Suspension, USP 400 mg/ 10mL (10 mL UD cups in boxes of 20 cups), Rx Only, Dist. By McKesson Packaging Services a business unit of McKesson Corporation 7101 Weddington Rd. Concord, NC 28027, NDC 63739-549-51
Reason
Subpotent Drug: Out of specification for assay (stability testing)
Identifiers
| code_info | Lot #: 0114588, Exp 10/18 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0338-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.